Lapidus Stanley's Form 4 filing
Lucid Diagnostics Inc. (LUCD) · filed Sep 27, 2023
- Accession no.
- 0001062993-23-018552
- Filed
- Sep 27, 2023
- Trade date
- Sep 25-26, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $43.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lapidus StanleyCIK 0001678195 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | Common stock | SSaleDisposed | −200 | $1.43 | −$286 | 131,339 | Direct | |
| Sep 26, 2023 | Common stock | SSaleDisposed | −10,000 | $1.47 | −$14,700 | 121,339 | Direct | |
| Sep 26, 2023 | Common stock | SSaleDisposed | −10,000 | $1.43 | −$14,300 | 111,339 | Direct | |
| Sep 26, 2023 | Common stock | SSaleDisposed | −9,747 | $1.45 | −$14,133.15 | 101,592 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.